FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

17520511000001104: Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2120181000001111 Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2120191000001113 Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60551501000001114 Irinotecan 40mg/2ml concentrate for solution for infusion vials (Generics (UK) Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
60551601000001113 Irinotecan 40mg/2ml concentrate for solution for infusion vials (Generics (UK) Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
92774401000001117 Irinotecan 40mg/2ml concentrate for solution for infusion vials (Mylan Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
105709201000001110 Irinotecan 40mg/2ml concentrate for solution for infusion vials (Mylan) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Is a Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has active ingredient Irinotecan hydrochloride true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has manufactured dose form Infusion concentrate false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has specific active ingredient Irinotecan hydrochloride trihydrate false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has specific active ingredient Irinotecan hydrochloride trihydrate true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Is a Irinotecan 40mg/2ml solution for infusion vials false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Is a Irinotecan 40mg/2ml solution for infusion vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) 1 vial Has AMP True Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start